Data_Sheet_1_The impact of supplementing vitamin D through different methods on the prognosis of COVID-19 patients: a systematic review and meta-analysis.PDF

ObjectiveTo analyze the impact of different methods of Vitamin D administration on the prognosis of COVID-19 patients.MethodsA comprehensive literature search was conducted across four databases: PubMed, Embase, Web of Science, and Cochrane, up to January 5, 2024. Eligible studies included randomized controlled trials and cohort studies that compared Vitamin D supplementation with control groups in COVID-19 patients. Outcomes of interest were mortality rate, ICU (Intensive Care Unit) admission rate, length of hospital stay, and endotracheal intubation rate. Subgroup analyses were performed based on the dosing regimen (single-dose vs. continuous-dose), total Vitamin D intake within 14 days (≥100,000 IU vs.

旨在分析不同维生素D给药方式对COVID-19患者预后的影响。方法：通过PubMed、Embase、Web of Science和Cochrane四大数据库进行全面的文献检索，截止至2024年1月5日。纳入符合条件的研究包括比较COVID-19患者中维生素D补充剂与安慰剂组的随机对照试验和队列研究。关注的结局指标包括死亡率、重症监护病房（ICU）入住率、住院时间和气管插管率。根据给药方案（单剂量与持续剂量）、14天内总维生素D摄入量（≥100,000 IU与<100,000 IU）进行了亚组分析。